gilteritinib
astellas pharmaceuticals
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'gilteritinib']
#eha2022 key messages for flt3mut aml:
-test flt3 at disease progression
-gilteritinib&gt;savage chemo in r and more successful bridge to transplant
-deeper r mission pre hsct better outcomes
-maintenance post hsct= better outcome 